About
Technology
Issues
FAQ
Links
Official Page
Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.